Alkaline Phosphatase (ALP) Test

Alkaline Phosphatase (ALP) Test in Pediatrics

Key Points

  • ALP levels vary significantly with age and growth velocity in children
  • Peak levels occur during infancy and puberty
  • Bone and liver isoenzymes predominate in pediatric populations
  • Critical for bone metabolism assessment and liver function monitoring

Normal Ranges by Age

  • Newborns: 150-400 U/L
  • Infants (1-12 months): 150-450 U/L
  • Children (1-9 years): 125-320 U/L
  • Adolescents:
    • During growth spurt: 300-850 U/L
    • Post-growth spurt: 100-300 U/L

Biochemistry and Function

  • Major Isoenzymes:
    • Bone-specific ALP (BALP): 80-90% in growing children
    • Liver ALP: 10-20% in children
    • Intestinal ALP: minimal contribution
    • Placental ALP: relevant only in newborns
  • Physiological Roles:
    • Hydroxyapatite crystal formation
    • Calcium and phosphate homeostasis
    • Bone mineralization
    • Collagen synthesis regulation

Growth-Related Changes

ALP variations correlate with:

  • Growth velocity
  • Pubertal stage
  • Bone turnover rate
  • Skeletal maturation

Clinical Indications

Elevated ALP Assessment

  • Bone Disorders:
    • Rickets
    • Healing fractures
    • Osteogenesis imperfecta
    • Bone malignancies
  • Liver Conditions:
    • Biliary obstruction
    • Hepatitis
    • Drug-induced liver injury

Decreased ALP Investigation

  • Genetic Conditions:
    • Hypophosphatasia
    • Wilson's disease
  • Nutritional Deficiencies:
    • Zinc deficiency
    • Severe malnutrition

Result Analysis

Elevated ALP Interpretation

  • Physiological causes:
    • Growth spurts
    • Bone healing
    • Early pregnancy
  • Pathological elevations:
    • 2-3x normal: Suggest investigation
    • 3-5x normal: Significant pathology likely
    • >5x normal: Urgent evaluation needed

Additional Testing Considerations

  • Concurrent tests:
    • Calcium and phosphorus
    • Vitamin D levels
    • Liver function tests
    • PTH levels when indicated

Special Considerations

Pre-analytical Variables

  • Timing considerations:
    • Diurnal variation
    • Growth phase assessment
    • Recent physical activity
  • Sample handling:
    • Temperature sensitivity
    • Storage conditions
    • Processing time

Monitoring Considerations

  • Serial measurements:
    • Timing intervals
    • Growth rate correlation
    • Treatment response assessment
  • Documentation needs:
    • Growth velocity
    • Pubertal stage
    • Recent illnesses
    • Medication changes


Further Reading
Powered by Blogger.